Andrea F. Patenaude, PhD, of Dana-Farber Cancer Institute, discusses the challenges to implementing standards for pediatric and adolescent psycho-oncology and looks ahead at next steps in the field.
Christopher J. Recklitis, PhD, MPH, of the Dana-Farber Cancer Institute, discusses what is known about suicide after cancer, the risks faced by prostate cancer patients within the first year after diagnosis, and challenges across the treatment trajectory
Allison J. Applebaum, PhD, and William S. Breitbart, MD, of Memorial Sloan Kettering Cancer Center, discuss a powerful treatment approach that is grounded in a moving personal story.
Lori Wiener, PhD, DCSW, LCSW-C, of the National Cancer Institute, and Paul B. Jacobsen, PhD, of the Moffitt Cancer Center, discuss the highlights of this year’s meeting, which for the first time brings together the international and American psychosocial oncology societies.
Irene Higginson, MD, of Cicely Saunders International, discusses the goals of psychosocial palliative care for patients around the world with advanced cancer.
Mark Lazenby, PhD, APRN, FAPOS, of the Yale School of Nursing, discusses the APOS–ACCC project to screen for psychosocial distress in community cancer centers. These model programs improve patient care and the patient experience.
